INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 163 filers reported holding INSMED INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $690,000 | -39.0% | 20,256 | -40.4% | 0.00% | -40.0% |
| Q4 2020 | $1,131,000 | +2.5% | 33,967 | -1.0% | 0.01% | 0.0% |
| Q3 2020 | $1,103,000 | +23.2% | 34,314 | +5.6% | 0.01% | +25.0% |
| Q2 2020 | $895,000 | +36.2% | 32,484 | -20.8% | 0.00% | 0.0% |
| Q1 2020 | $657,000 | +9.3% | 41,014 | +62.9% | 0.00% | +33.3% |
| Q4 2019 | $601,000 | +58.2% | 25,183 | +16.9% | 0.00% | +50.0% |
| Q3 2019 | $380,000 | -27.6% | 21,538 | +5.1% | 0.00% | -33.3% |
| Q2 2019 | $525,000 | -11.9% | 20,498 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $596,000 | +169.7% | 20,498 | +22.0% | 0.00% | +200.0% |
| Q4 2018 | $221,000 | -82.9% | 16,808 | -73.7% | 0.00% | -85.7% |
| Q3 2018 | $1,292,000 | -33.9% | 63,873 | -22.7% | 0.01% | -36.4% |
| Q2 2018 | $1,955,000 | +16.9% | 82,680 | +11.3% | 0.01% | +22.2% |
| Q1 2018 | $1,673,000 | +411.6% | 74,280 | +124.1% | 0.01% | +200.0% |
| Q2 2016 | $327,000 | – | 33,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |